The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 2108-2119

  Cooper, Lee A D ^a,c   Gutman, David A ^a,c   Chisolm, Candace ^b   Appin, Christina ^b   Kong, Jun ^a,c   Rong, Yuan ^b   Kurc, Tahsin ^a,c   Van Meir, Erwin G ^a   Saltz, Joel H ^a,b,c   Moreno, Carlos S ^a,b,c   Brat, Daniel J ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; STAT3 PROTEIN; TRANSCRIPTION FACTOR RUNX1;

ANGIOGENESIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER PROGNOSIS; CELL DEATH; CELL HYPOXIA; CELL STRUCTURE; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENE REGULATORY NETWORK; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE; MESENCHYME; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT;

CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL HYPOXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLIOBLASTOMA; HUMANS; MACROPHAGES; MESENCHYMAL STEM CELLS; MUTATION; NECROSIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84860247330     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.040     Document Type: Article

References (31)

1. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee WHO classification of tumours of the central nervous system 4th ed. 2007 Intl. Agency for Research Lyon
2. CBTRUS CBTRUS statistical report: primary brain and central nervous system tumors in the United States in 2004-2006 2010 Central Brain Tumor Registry of the United States Hinsdale, IL
3. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, R.O. Mirimanoff Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
4. H.S. Phillips, S. Kharbanda, R. Chen, W.F. Forrest, R.H. Soriano, T.D. Wu, A. Misra, J.M. Nigro, H. Colman, L. Soroceanu, P.M. Williams, Z. Modrusan, B.G. Feuerstein, K. Aldape Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 2006 157 173
5. R.G. Verhaak, K.A. Hoadley, E. Purdom, V. Wang, Y. Qi, M.D. Wilkerson, C.R. Miller, L. Ding, T. Golub, J.P. Mesirov, G. Alexe, M. Lawrence, M. O'Kelly, P. Tamayo, B.A. Weir, S. Gabriel, W. Winckler, S. Gupta, L. Jakkula, H.S. Feiler, J.G. Hodgson, C.D. James, J.N. Sarkaria, C. Brennan, A. Kahn, P.T. Spellman, R.K. Wilson, T.P. Speed, J.W. Gray, M. Meyerson, G. Getz, C.M. Perou, D.N. Hayes Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA. IDH1, EGFR, and NF1 Cancer Cell 17 2010 98 110
6. Cancer Genome Atlas Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
7. H. Noushmehr, D.J. Weisenberger, K. Diefes, H.S. Phillips, K. Pujara, B.P. Berman, F. Pan, C.E. Pelloski, E.P. Sulman, K.P. Bhat, R.G. Verhaak, K.A. Hoadley, D.N. Hayes, C.M. Perou, H.K. Schmidt, L. Ding, R.K. Wilson, D. Van Den Berg, H. Shen, H. Bengtsson, P. Neuvial, L.M. Cope, J. Buckley, J.G. Herman, S.B. Baylin, P.W. Laird, K. Aldape Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma Cancer Cell 17 2010 510 522
8. M.S. Carro, W.K. Lim, M.J. Alvarez, R.J. Bollo, X. Zhao, E.Y. Snyder, E.P. Sulman, S.L. Anne, F. Doetsch, H. Colman, A. Lasorella, K. Aldape, A. Califano, A. Iavarone The transcriptional network for mesenchymal transformation of brain tumours Nature 463 2010 318 325
9. L.A. Cooper, J. Kong, D.A. Gutman, F. Wang, S.R. Cholleti, T.C. Pan, P.M. Widener, A. Sharma, T. Mikkelsen, A.E. Flanders, D.L. Rubin, E.G. Van Meir, T.M. Kurc, C.S. Moreno, D.J. Brat, J.H. Saltz An integrative approach for in silico glioma research IEEE Trans Biomed Eng 57 2010 2617 2621
10. A. Perry, D.J. Brat Practical surgical pathology: a diagnostic approach 2010 Elsevier Philadelphia
11. D.J. Brat, R.A. Prayson, T.C. Ryken, J.J. Olson Diagnosis of malignant glioma: role of neuropathology J Neurooncol 89 2008 287 311
12. V.G. Tusher, R. Tibshirani, G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 2011 5116 5121
13. L.A. Cooper, D.A. Gutman, Q. Long, B.A. Johnson, S.R. Cholleti, T. Kurc, J.H. Saltz, D.J. Brat, C.S. Moreno The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas PLoS ONE 5 2010 e12548
14. A.R. Dabney Classification of microarrays to nearest centroids Bioinformatics 21 2005 4148 4154
15. Y. Rong, V.E. Belozerov, C. Tucker-Burden, G. Chen, D.L. Durden, J.J. Olson, E.G. Van Meir, N. Mackman, D.J. Brat Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity Cancer Res 69 2009 2540 2549
16. Y. Rong, D.E. Post, R.O. Pieper, D.L. Durden, E.G. Van Meir, D.J. Brat PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma Cancer Res 65 2005 1406 1413
17. Y. Rong, F. Hu, R. Huang, N. Mackman, J.M. Horowitz, R.L. Jensen, D.L. Durden, E.G. Van Meir, D.J. Brat Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms Cancer Res 66 2006 7067 7074
18. D.E. Post, E.M. Sandberg, M.M. Kyle, N.S. Devi, D.J. Brat, Z. Xu, M. Tighiouart, E.G. Van Meir Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4 Cancer Res 67 2007 6872 6881
19. Y. Rong, D.L. Durden, E.G. Van Meir, D.J. Brat " Pseudopalisading" necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis J Neuropathol Exp Neurol 65 2006 529 539
20. B. Kaur, C. Tan, D.J. Brat, D.E. Post, E.G. Van Meir Genetic and hypoxic regulation of angiogenesis in gliomas J Neurooncol 70 2004 229 243
21. E. Van Meir, Y. Sawamura, A.C. Diserens, M.F. Hamou, N. de Tribolet Human glioblastoma cells release interleukin 6 in vivo and in vitro Cancer Res 50 1990 6683 6688
22. B. Kaur, F.W. Khwaja, E.A. Severson, S.L. Matheny, D.J. Brat, E.G. Van Meir Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis Neuro Oncol 7 2005 134 153
23. M.N. Bradley, L. Zhou, S.T. Smale C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages Mol Cell Biol 23 2003 4841 4858
24. S.K. Roy, J. Hu, Q. Meng, Y. Xia, P.S. Shapiro, S.P. Reddy, L.C. Platanias, D.J. Lindner, P.F. Johnson, C. Pritchard, G. Pages, J. Pouyssegur, D.V. Kalvakolanu MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma Proc Natl Acad Sci USA 99 2002 7945 7950
25. H. Yu, D. Pardoll, R. Jove STATs in cancer inflammation and immunity: a leading role for STAT3 Nat Rev Cancer 9 2009 798 809
26. D.J. Brat, A.A. Castellano-Sanchez, S.B. Hunter, M. Pecot, C. Cohen, E.H. Hammond, S.N. Devi, B. Kaur, E.G. Van Meir Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population Cancer Res 64 2004 920 927
27. I. Desbaillets, A.C. Diserens, N. de Tribolet, M.F. Hamou, E.G. Van Meir Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma Oncogene 18 1999 1447 1456
28. D.J. Brat, A. Castellano-Sanchez, B. Kaur, E.G. Van Meir Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation Adv Anat Pathol 9 2002 24 36
29. A.M. Spence, M. Muzi, K.R. Swanson, F. O'Sullivan, J.K. Rockhill, J.G. Rajendran, T.C. Adamsen, J.M. Link, P.E. Swanson, K.J. Yagle, R.C. Rostomily, D.L. Silbergeld, K.A. Krohn Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival Clin Cancer Res 14 2008 2623 2630
30. D.J. Brat, A.C. Bellail, E.G. Van Meir The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis Neuro Oncol 7 2005 122 133
31. S.M. Raza, G.N. Fuller, C.H. Rhee, S. Huang, K. Hess, W. Zhang, R. Sawaya Identification of necrosis associated genes in glioblastoma by cDNA micro-array analysis Clin Cancer Res 10 2004 212 221